PMC5465418_01
PMC5465418_02
The time course of major adverse events in the lung cancer patient with xeroderma pigmentosum after receiving adjuvant chemotherapy: cisplatin at 80 mg/m2 and vinorelbine at 25 mg/m2 on day 1. Bold line: alanine aminotransferase (ALT) levels, thin line: total bilirubin levels, broken line: creatinine levels.
1349-7235-56-0979-g001.jpg
PMC5465418_02_1349-7235-56-0979-g001.jpg
g001
Fig. 1 shows the time course of the major adverse events experienced following chemotherapy.
PMC5465418_03
The time course of major adverse events in the esophageal cancer patient with xeroderma pigmentosum after receiving adjuvant chemotherapy: cisplatin at 80 mg/m2 on day 1 and 5-fluorouracil continuous infusion at 800 mg/m2/day on day 1 through day 3. The infusion of 5-fluouracil was discontinued on day 4. Bold line: alanine aminotransferase (ALT) levels, thin line: total bilirubin levels; broken line: creatinine levels.
1349-7235-56-0979-g002.jpg
PMC5465418_03_1349-7235-56-0979-g002.jpg
g002
The time course of the major adverse events experienced following chemotherapy is shown in Fig. 2.